Sodium-glucose cotransporter-2 inhibition for heart failure with preserved ejection fraction and chronic kidney disease with or without type 2 diabetes mellitus: a narrative review

BACKGROUND: Heart failure (HF), chronic kidney disease (CKD), and type 2 diabetes mellitus (T2DM) are common and interrelated conditions, each with a significant burden of disease. HF and kidney disease progress through pathophysiologic pathways that culminate in end-stage disease, for which T2DM is...

Descripción completa

Detalles Bibliográficos
Autores principales: Mentz, Robert J., Brunton, Stephen A., Rangaswami, Janani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655322/
https://www.ncbi.nlm.nih.gov/pubmed/37974185
http://dx.doi.org/10.1186/s12933-023-02023-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655322/
https://www.ncbi.nlm.nih.gov/pubmed/37974185
http://dx.doi.org/10.1186/s12933-023-02023-y

Ejemplares similares